Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1

ITALSGEN consortium, Kreshnik B Ahmeti, Senda Ajroud-Driss, Ammar Al-Chalabi, Peter M Andersen, Jennifer Armstrong, Anne Birve, Hylke M Blauw, Robert H Brown, Lucie Bruijn, Wenjie Chen, Adriano Chio, Mary C Comeau, Simon Cronin, Frank P Diekstra, Athina Soraya Gkazi, Jonathan D Glass, Josh D Grab, Ewout J Groen, Jonathan L HainesOrla Hardiman, Scott Heller, Jie Huang, Wu-Yen Hung, James M Jaworski, Ashley Jones, Humaira Khan, John E Landers, Carl D Langefeld, P Nigel Leigh, Miranda C Marion, Russell L McLaughlin, Vincent Meininger, Judith Melki, Jack W Miller, Gabriele Mora, Margaret A Pericak-Vance, Evadnie Rampersaud, Wim Robberecht, Laurie P Russell, Francois Salachas, Christiaan G Saris, Aleksey Shatunov, Christopher E Shaw, Nailah Siddique, Teepu Siddique, Bradley N Smith, Robert Sufit, Simon Topp, Bryan J Traynor, Caroline Vance

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Amyotrophic lateral sclerosis (ALS) is the third most common adult-onset neurodegenerative disease. Individuals with ALS rapidly progress to paralysis and die from respiratory failure within 3 to 5 years after symptom onset. Epidemiological factors explain only a modest amount of the risk for ALS. However, there is growing evidence of a strong genetic component to both familial and sporadic ALS risk. The International Consortium on Amyotrophic Lateral Sclerosis Genetics was established to bring together existing genome-wide association cohorts and identify sporadic ALS susceptibility and age at symptom onset loci. Here, we report the results of a meta-analysis of the International Consortium on Amyotrophic Lateral Sclerosis Genetics genome-wide association samples, consisting of 4243 ALS cases and 5112 controls from 13 European ancestry cohorts from across the United States and Europe. Eight genomic regions provided evidence of association with ALS, including 9p21.2 (rs3849942, odds ratio [OR] = 1.21; p = 4.41 × 10(-7)), 17p11.2 (rs7477, OR = 1.30; p = 2.89 × 10(-7)), and 19p13 (rs12608932, OR = 1.37, p = 1.29 × 10(-7)). Six genomic regions were associated with age at onset of ALS. The strongest evidence for an age of onset locus was observed at 1p34.1, with comparable evidence at rs3011225 (R(2)(partial) = 0.0061; p = 6.59 × 10(-8)) and rs803675 (R(2)(partial) = 0.0060; p = 6.96 × 10(-8)). These associations were consistent across all 13 cohorts. For rs3011225, individuals with at least 1 copy of the minor allele had an earlier average age of onset of over 2 years. Identifying the underlying pathways influencing susceptibility to and age at onset of ALS may provide insight into the pathogenic mechanisms and motivate new pharmacologic targets for this fatal neurodegenerative disease.

Original languageEnglish
Pages (from-to)357.e7-19
JournalNeurobiology of Aging
Issue number1
Publication statusPublished - Jan 2013

Keywords / Materials (for Non-textual outputs)

  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Amyotrophic Lateral Sclerosis
  • Chromosomes, Human, Pair 1
  • Europe
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Male
  • Meta-Analysis as Topic
  • Middle Aged
  • Polymorphism, Single Nucleotide
  • United States


Dive into the research topics of 'Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1'. Together they form a unique fingerprint.

Cite this